longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Bioceres Crop Solutions Faces Adverse Damages Ruling in New York Court

Tip Ranks
Sep 21, 2026 at 10:28 AM
LongbridgeAII'm LongbridgeAI, I can summarize articles.

Bioceres Crop Solutions (BIOX) announced that the New York Supreme Court granted summary judgment for damages in a lawsuit, awarding plaintiffs requested amounts plus interest and $1.4 million in legal costs. The company intends to appeal, leaving financial impact uncertain. Analysts maintain a 'Hold' rating with a $2.00 price target, while TipRanks’ AI tool rates BIOX as Neutral due to weakened profitability, high leverage, and litigation risks.

Bioceres Crop Solutions ( (BIOX) ) has issued an announcement.

On September 18, 2026, Bioceres Crop Solutions disclosed that the Supreme Court of the State of New York granted a motion for summary judgment on damages against the company in the case Jasper Lake Ventures One LLC, et al. v. Bioceres Crop Solutions Corp., et al. The ruling awards plaintiffs the damages requested, including per diem interest accruing from July 23, 2026, until judgment is entered.

The court also ordered Bioceres and other guarantor defendants to pay $1.4 million in costs and attorneys’ fees on a joint and several basis, creating a potentially material legal and financial obligation. Bioceres and the guarantor defendants have stated their intention to appeal the ruling, signaling that the dispute remains active and that the ultimate financial impact on the company and its stakeholders is still uncertain.

The most recent analyst rating on (BIOX) stock is a Hold
with a $2.00 price target.
To see the full list of analyst forecasts on Bioceres Crop Solutions stock,
see the BIOX Stock Forecast page.

Spark’s Take on BIOX Stock

According to Spark, TipRanks’ AI Analyst, BIOX is a Neutral.

The score is held down primarily by sharply weakened profitability and elevated leverage, reinforced by an earnings-call backdrop of falling revenues, negative EBITDA, litigation/debt-acceleration risk and limited liquidity. Offsetting factors are improved operating/free cash flow and some near-term technical stabilization, but the longer-term trend and loss-making profile remain key constraints.

To see Spark’s full report on BIOX stock,
click here.

More about Bioceres Crop Solutions

Bioceres Crop Solutions Corp. is an Argentina-based agricultural biotechnology company focused on crop productivity solutions. The company develops and commercializes technologies and inputs aimed at improving yields and sustainability for growers, with its securities registered for trading in the U.S. market.

Operating as a foreign private issuer under U.S. securities regulations, Bioceres files periodic reports with the Securities and Exchange Commission, reflecting its dual presence in Latin American agriculture and international capital markets.

Average Trading Volume: 282,108

Technical Sentiment Signal: Sell

Current Market Cap: $22.78M

Learn more about BIOX stock on TipRanks’ Stock Analysis page.

Login to unlock1,926characters for free

Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.

Bioceres Crop Solutions

Bioceres Crop Solutions

BIOX.US

Open

--

High

--

Low

--

Prev Close

--

P/ETTM

--

Market Cap

--

LongbridgeAI